Professor of Medicine-UCSD-Molecular cardiologist-Entrepreneur- Uncovering new therapeutic targets for genetic based cardiac diseases #ARVC Tweets are my own.
๐ฃ๐ Exciting news! Our labโs new paper in #CirculationHeartFailure reports a gene therapy for arrhythmogenic cardiomyopathy. Restoring connexin-43 improves electrical & mechanical coupling, rescues disease & extends survival across severe ACM genotypes.
https://t.co/Hd72GDLRJW
Iโm honored to keynote @UOHIResearch Research Day and share our bench-to-bedside work toward therapies for arrhythmogenic cardiomyopathy. #ARVC#HeartResearch ๐งฌ๐ซ
Research Day is only a few days away!
Weโre thrilled to welcome our keynote, Dr. Farah Sheikh, as she takes us from bench to bedside in developing therapies for genetic heart disease. ๐ฅผ๐ฌ
Donโt miss it- you can watch online or in-person!
Register here:https://t.co/nc92wg294l
๐ฃ๐ Exciting news! Our labโs new paper in #CirculationHeartFailure reports a gene therapy for arrhythmogenic cardiomyopathy. Restoring connexin-43 improves electrical & mechanical coupling, rescues disease & extends survival across severe ACM genotypes.
https://t.co/Hd72GDLRJW
@MarbanLab @SmidtHeart @UCSD@SumeetSChugh@EugenioCingolan@rrogerslab@TheIbrahimLab Thank you @MarbanLab for the kind words & hospitality! Grateful for the chance to share our teamโs work on #ARVC and the journey toward PKP2-targeted AAV gene therapy. Appreciate the opportunity to meet & discuss with the wonderful faculty @SmidtHeart!
๐ข New publication on AAVrh10-based plakophilin-2 gene therapy, showcasing exciting preclinical data supporting the recent encouraging LX2020 Phase 1/2 trial results in ARVC patients. Thanks to Sheikh lab team & LEXEO Therapeutics! #ARVC#GeneTherapy#PKP2 https://t.co/nEB3VLhtlA